Accueil › Mélanome › Caroline du Nord › Durham
Essais cliniques pour Mélanome à Durham, NC
21 études pour Mélanome recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Recrutement en coursPhase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
DESTINY-PANTUMOUR04
Recrutement en coursÉtude observationnelle
- Research Site, Durham
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Recrutement en coursPhase 3
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Recrutement en coursPhase 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recrutement en coursÉtude observationnelle
- UNC- Chapel Hill, Chapel Hill · à 10 mi
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Recrutement en coursPhase 1/2
- University of North Carolina, Chapel Hill · à 10 mi
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Recrutement en coursPhase 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
Recrutement en coursÉtude observationnelle
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Recrutement en coursPhase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Recrutement en coursPhase 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Recrutement en coursPhase 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Recrutement en coursPhase 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
Recrutement en coursPhase 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Recrutement en coursPhase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Recrutement en coursPhase 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Recrutement en coursPhase 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chapel Hill · à 10 mi
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Recrutement en cours
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recrutement en cours
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · à 13 mi
Essais pour Mélanome dans d'autres villes
- Houston, TX59 études
- New York City, NY38 études
- Los Angeles, CA34 études
- Nashville, TN33 études
- Pittsburgh, PA31 études
- Boston, MA26 études
- Philadelphia, PA23 études
- San Francisco, CA22 études
- Atlanta, GA21 études
- St. Louis, MO21 études
- Columbus, OH21 études
- Salt Lake City, UT21 études
Autres études à Durham
- Cancer du sein63 études
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules39 études
- Myélome multiple37 études
- Cancer métastatique33 études
- Leucémie aiguë myéloïde33 études
- Cancer du poumon32 études
- Cancer de la prostate32 études
- Cancer colorectal28 études
- Leucémie lymphocytaire chronique27 études
- Cancer de l'ovaire27 études
- Insuffisance cardiaque26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.